To test the hypothesis that histological chorioamnionitis (CA) is not associated with increased risk of early onset intraventricular hemorrhage (IVH).
INTRODUCTION
Release of inflammatory cytokines following chorioamnionitis (CA) has been associated with fetal and neonatal brain injury, including periventricular leukomalacia (PVL) and intraventricular hemorrhage (IVH). [1] [2] [3] [4] [5] Neverthless, the link between CA and brain lesions, especially intraventricular hemorrhage, remains controversial.
Several lines of evidence suggest that the association between CA and IVH may be causal in origin and is biologically plausible. 6 Although the hypothesis that CA may cause IVH is theoretically possible, if the association between the two events is causal in origin, one might expect that the IVH would be evident at or soon after birth. Earlier studies linking CA and IVH were retrospective, did not detect the presence of IVH that may have occurred ante-or intra-partum with head ultrasound soon after birth, and did not specify if the IVH was of early or of late onset. The increased risk of fetal and neonatal IVH with CA in those studies might have been related to the timing of head ultrasound and other pre-and postnatal confounders. Indeed, it is important to know if CA plays a role in the pathogenesis of early-onset IVH as opposed to late-onset IVH, IVH of early-onset is more likely to progress to a higher grade and is known to be associated with greater neonatal mortality rate and risk of cerebral parenchymal injury with subsequent neurodevelopmental disability in survivors. 6, 7 We hypothesized that histological CA does not independently affect incidence of early onset IVH.
METHODS
The protocol design was a prospective, observational study. Clinical data were prospectively collected for 62 consecutive neonates, born at or before 28 weeks gestation, who had serial head ultrasound scans (HUSs) performed starting at 15 to 30 minutes after birth for evaluation of IVH in the neonatal intensive care unit at the State University of New York at Stony Brook. Placental histology for CA were performed during subsequent weeks by a pathologist unaware of the head ultrasound results. Histopathological diagnosis of CA was based on clearly defined, clinically relevant, and pathologically reproducible standardized diagnostic framework described by Redline et al., 8 and included presence of necrotizing CA or subchorionic microabscesses with or without a coexisting fetal vascular response, either umbilical or chorionic vasculitis. The first head ultrasound at 15 to 30 minutes of age was performed with the SonoSite 180 plus portable machine, the validity of which was established by us previously. 9 Follow-up regular head ultrasounds were performed at less than 24 hours of life, at 48 to 72 postnatal hours, again during day 5 to 7 and then in the 3rd or 4th weeks of life. If any abnormality was identified, they were carried out at least on a weekly basis. For this study, the head ultrasound images were read by one of the investigators (ARS) and every scan on each infant was re-evaluated by an experienced radiologist blinded to the infant's perinatal details. IVH was classified as Grades 1 to 4 according to Volpe's classification. 10 Grade 1 represents germinal matrix hemorrhage only with no obvious IVH. Grade 2 represents IVH occupying 10 to 50% of ventricular area on parasagittal view. Grade 3 is IVH with hemorrhage occupying >50% of ventricular area on parasagittal view. Grade 4 represents severe IVH with associated periventricular or parenchymal echodensity. An IVH (grades I to IV) prior to 72 postnatal hours of life was deemed an early hemorrhage. This study was approved by the Institutional Review Board of the State University of New York at Stony Brook and parental consent was taken before the infants were enrolled for the study.
Sample Size Calculation and Statistical Analysis
From prior data showing preterm, very low birth weight infants with inflamed amnion are at threefold greater risk for IVH, 11, 12 and with a 15% incidence of early IVH, 28 infants were needed in each group (CA and non-CA) to find a significant association with an a of 0.05 and b of 0.20.
For statistical analysis, we used the Student's t-test and w 2 test to compare values between the two groups of the study infants. The effect of potential confounding perinatal variables such as birth weight, gestational age, sex, 5 minute Apgar score, need for cardiopulmonary resuscitation and volume resuscitation at birth, umbilical arterial pH, presence of a pneumothorax on day one, number of doses of surfactant on day one, prenatal glucocorticoid use, need for tocolytic therapy, mode of delivery, platelet count at birth, and presence of histopathological evidence of CA, on the incidence of IVH was tested by stepwise logistic multivariate regression analysis. Data were processed using statistical software SPSS 10.7 (SPSS Inc., Chicago, IL, USA).
RESULTS
Nine of the 62 (14.5%) neonates had early IVH. Of the 62 neonates, 29 were born to women with histological CA and 33 without CA. Mean birth weight of all study infants was 884 grams±SD 271 (range 386 to 1405 grams) and mean gestation 26.2 weeks±SD 1.6 (range 23.4 to 28.6 weeks). Table 1 illustrates the neonatal and obstetric characteristics of the study infants. Infants from both the groups did not differ in birth weight, gestational age, sex, umbilical arterial pH, Apgar score of less than 7 at 5 minutes, mode of delivery, prenatal steroids, tocolytics, need for resuscitation, development of pneumothorax, and platelet counts at birth. Only eight of the study infants (two in the CA group and six in the non-CA group) were born to women with pregnancy-induced hypertension.
HUSs at birth revealed only one infant with a bilateral Grade 3 IVH and two infants with abnormal scans (ventriculomegaly in one, and cystic encephalomalacia in one) in the CA group, while four infants had IVH (bilateral Grade I in two, bilateral Grade II in one, and bilateral Grade III in one) and two infants had ventriculomegaly without IVH in the non-CA group. Repeat HUS results on day one were identical to Sonosite ultrasound results at birth.
Follow-up HUSs at 48 to 72 hours of life revealed two more infants with IVH (bilateral Grade II in one, and left Grade IV in one) in the CA and two infants with IVH (bilateral Grade II in one, and bilateral Grade IV in one) in the non-CA group. These four infants had normal HUSs on day one of life. Early IVH rates in the study infants (3/29 in CA group vs 6/33 in non-CA group) were similar ( p ¼ 0.48).
Step-wise logistic regression confirmed that none of the perinatal variables (e.g. birth weight, gestational age, sex, Apgar score at 5 minutes, CPR, and volume resuscitation at birth, umbilical arterial pH, development of pneumothorax on day one, surfactant doses on day one of life, prenatal steroid use, use of tocolysis, mode of delivery, or platelet count at birth) including presence of CA was associated with early onset IVH.
Two infants in each group with early IVH died before 2 weeks of age. Only one of the five surviving infants from both groups with early IVH developed PVL at 4 weeks ( Table 2) .
Five additional infants from the CA group demonstrated IVH at more than 72 hours of life (late onset IVH), and two of those infants subsequently developed PVL. In contrast, three additional non-CA infants had late IVH and none developed PVL.
DISCUSSION
Proinflammatory cytokines are a major component of systemic inflammatory response, local activation of endothelial inflammation processes, and premature birth. 13 Inflammation of the fetomaternal unit may lead to CA and omphalovasculitis, which are regarded as definite signs of fetal involvement. [13] [14] [15] [16] Cytokine pathways have been proposed as a possible link between systemic infection of the fetomaternal unit and consecutive neonatal brain injury, which include intraventricular hemorrhage, ventricular enlargement, and white matter damage including cystic periventricular leukomalacia. 2,4,5,6,13,17 -19 CA leads to the release of vasoactive inflammatory cytokines which are able to mediate blood-brain barrier alterations, intravascular cells adhesion, coagulation, and thromboses. In turn, this can lead to endothelial damage within the fragile germinal matrix capillaries or the vascular connections between the germinal matrix and the subependymal venous network. 2, 5, 6, 20, 21 The results of our study, however, suggest that CA is not a significant factor in the pathogenesis of IVH in extremely premature infants and, since CA did not increase early onset IVH, the association between the two events is unlikely causal in origin.
Previous studies 5, 6, 11, 12 did not specifically elucidate the role of CA in the pathogenesis of early onset IVH. In fact unlike our study, the higher incidence of IVH associated with CA might have been mostly of late onset. 21 Our data indicate that CA is not associated with an increased risk of early IVH. The late onset IVH rates in the surviving infants (5/27 in CA group vs 3/30 in non-CA group) were also similar (p ¼ 0.45), but a valid conclusion regarding late IVH can not be drawn, as the data were not available in five infants who died before the day 5 to 7 ultrasound could be performed. We speculate that this reduction in early IVH might have been related to inhibition of early inflammatory responses by prenatal steroids treatment, received by nearly 90% of the parturients in the study. Paradoxically, this may result in later enhanced or rebound inflammation and damage, as is the case for the increased risk of fetal lung inflammation with maternal glucocorticoids. 22 Additional studies are needed to determine if the increased severity of systemic and local hemodynamic changes in infants born to women with CA in presence of cytokine-induced cerebral endothelial damage as part of the enhanced late neonatal inflammatory response syndrome leads to an increased vulnerability to the development of late onset IVH.
In our study, the first head ultrasound which was done soon after birth detected one infant with bilateral Grade III IVH in the CA group and four infants with IVH (bilateral Grade I in two, bilateral Grade II in one, bilateral grade III in one) in the non-CA group. As IVH in those infants were evident soon after birth, these hemorrhages must have occurred in utero or during delivery. The international literature on in utero intracranial hemorrhages in general, and IVH in particular, is scarce and, in most cases, the cause of intracranial hemorrhage in utero is not known. 23 The infants from the non-CA group had a similar incidence of IVH at birth. Our data do not enlighten the role of CA in the pathogenesis of in utero IVH.
We chose histologic CA as the primary exposure because it is objective and that histopathological evidence of acute inflammatory placental lesions has been shown to be the best predictor of occurrence of neonatal IVH. 6 Cranial ultrasound was the imaging modality for detection of IVH in our study infants because it can be used at bedside and is cost-effective. Although cranial ultrasound detects germinal layer hemorrhage, intraventricular hemorrhage, hemorrhagic parenchymal infarction, and cystic periventricular leukomalacia, its sensitivity and specificity in detecting diffuse or subtle brain injury is poor based on pathologic correlation studies.
To conclude, CA is not associated with increased risk of early IVH. Additional studies are needed to determine if CA increased vulnerability for development of late onset IVH.
